Literature DB >> 7590140

The effect of omeprazole on human natural killer cell activity.

C Aybay1, T Imir, H Okur.   

Abstract

1. Omeprazole, an antiulcer drug, inhibits the gastric acid pump via blocking the parietal cell (H+ + K+)-ATPase. Omeprazole was also reported to have an inhibitory action on polymorphonuclear neutrophil activities. In the present study the potential effect of omeprazole on human natural killer cell (NK) activity was investigated. 2. Omeprazole decreased NK cytotoxic activity in a dose-dependent manner. 3. Degraded omeprazole showed a similar action. 4. In vitro NK inhibitory action of omeprazole and its acid-degraded form was observed at the concentrations equal and higher than 18 microM (micromolar). 5. NK inhibitory action of omeprazole was recovered to 75% by washing away of the agent. 6. Omeprazole decreased the conjugate formation of effector and target cells by 50% at the concentration of 288 microM

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590140     DOI: 10.1016/0306-3623(94)00301-3

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  18 in total

1.  Mechanical manipulation of polymorphonuclear leukocyte plasma membranes with optical tweezers causes influx of extracellular calcium through membrane channels.

Authors:  A Holm; T Sundqvist; A Oberg; K E Magnusson
Journal:  Med Biol Eng Comput       Date:  1999-05       Impact factor: 2.602

2.  Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.

Authors:  Jason E Lang; Janet T Holbrook; Edward B Mougey; Christine Y Wei; Robert A Wise; W Gerald Teague; John J Lima
Journal:  Ann Am Thorac Soc       Date:  2015-06

3.  Correlation between proton pump inhibitors and risk of pyogenic liver abscess.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-04-22       Impact factor: 2.953

4.  Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?

Authors:  Alexander L Fohl; Randolph E Regal
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-06-06

Review 5.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 6.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

Review 7.  Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.

Authors:  Chun-Sick Eom; Christie Y Jeon; Ju-Won Lim; Eun-Geol Cho; Sang Min Park; Kang-Sook Lee
Journal:  CMAJ       Date:  2010-12-20       Impact factor: 8.262

Review 8.  Risk of fracture and pneumonia from acid suppressive drugs.

Authors:  Chun-Sick Eom; Sang-Soo Lee
Journal:  World J Methodol       Date:  2011-09-26

9.  Omeprazole inhibits natural killer cell functions.

Authors:  Huseyin Alkim; Selahattin Unal; Hamza Okur; Turgut Imir
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

10.  Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.

Authors:  Paul J Young; Sean M Bagshaw; Andrew B Forbes; Alistair D Nichol; Stephen E Wright; Michael Bailey; Rinaldo Bellomo; Richard Beasley; Kathy Brickell; Glenn M Eastwood; David J Gattas; Frank van Haren; Edward Litton; Diane M Mackle; Colin J McArthur; Shay P McGuinness; Paul R Mouncey; Leanlove Navarra; Dawn Opgenorth; David Pilcher; Manoj K Saxena; Steve A Webb; Daisy Wiley; Kathryn M Rowan
Journal:  JAMA       Date:  2020-02-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.